BRPI0604723A - método para prover composições oftálmicas oxidativamente estáveis - Google Patents

método para prover composições oftálmicas oxidativamente estáveis

Info

Publication number
BRPI0604723A
BRPI0604723A BRPI0604723-8A BRPI0604723A BRPI0604723A BR PI0604723 A BRPI0604723 A BR PI0604723A BR PI0604723 A BRPI0604723 A BR PI0604723A BR PI0604723 A BRPI0604723 A BR PI0604723A
Authority
BR
Brazil
Prior art keywords
providing
ophthalmic compositions
oxidatively stable
stable ophthalmic
oxidatively
Prior art date
Application number
BRPI0604723-8A
Other languages
English (en)
Inventor
Azaam Alli
Shivkumar Mahadevan
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BRPI0604723A publication Critical patent/BRPI0604723A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0005—Degasification of liquids with one or more auxiliary substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0036—Flash degasification
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0073—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0073—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042
    • B01D19/0078—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042 by vibration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D7/00—Sublimation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D7/00—Sublimation
    • B01D7/02—Crystallisation directly from the vapour phase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

MéTODO PARA PROVER COMPOSIçõES OFTáLMICAS OXIDATIVAMENTE ESTáVEIS. A presente invenção refere-se a um processo para aperfeiçoamento da estabilidade de uma solução oftalmicamente compatível compreendendo pelo menos um composto oftálmico oxidativamente instável.
BRPI0604723-8A 2005-09-30 2006-09-29 método para prover composições oftálmicas oxidativamente estáveis BRPI0604723A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/241,313 US20070077303A1 (en) 2005-09-30 2005-09-30 Methods for providing oxidatively stable ophthalmic compositions

Publications (1)

Publication Number Publication Date
BRPI0604723A true BRPI0604723A (pt) 2007-08-28

Family

ID=37619526

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0604723-8A BRPI0604723A (pt) 2005-09-30 2006-09-29 método para prover composições oftálmicas oxidativamente estáveis

Country Status (11)

Country Link
US (2) US20070077303A1 (pt)
EP (1) EP1769834A3 (pt)
JP (1) JP2007099768A (pt)
KR (1) KR20070037415A (pt)
CN (1) CN1939278A (pt)
AR (1) AR057526A1 (pt)
AU (1) AU2006225174B2 (pt)
BR (1) BRPI0604723A (pt)
CA (1) CA2561676A1 (pt)
SG (1) SG131101A1 (pt)
TW (1) TW200730468A (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466174B2 (en) * 2006-03-17 2013-06-18 Johnson & Johnson Vision Care, Inc. Methods for stabilizing oxidatively unstable compositions
PL3150209T3 (pl) 2006-03-31 2020-03-31 Vistakon Pharmaceuticals, Llc Leczenie alergii oczu
US20100178316A1 (en) * 2007-05-30 2010-07-15 Anuj Chauhan Extended release of bioactive molecules from silicone hydrogels
MX2012006401A (es) * 2009-12-03 2012-07-10 Lupin Ltd Proceso para preparar composiciones oftalmicas farmaceuticas.
CN103797403B (zh) * 2011-08-31 2016-10-19 庄臣及庄臣视力保护公司 具有改进的盐水配方的液体弯月形透镜
KR101703980B1 (ko) * 2013-12-30 2017-02-08 주식회사 삼양바이오팜 항산화제를 함유하지 않는 약학 조성물 및 그의 제조방법
KR101919436B1 (ko) * 2015-05-28 2018-11-16 주식회사 삼양바이오팜 안정화된 약학 조성물 및 그의 제조방법
GR1008942B (el) * 2015-10-14 2017-02-06 ΙΟΥΛΙΑ ΚΑΙ ΕΙΡΗΝΗ ΤΣΕΤΗ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "INTERMED ΑΒΕΕ" Μεθοδος παραγωγης σταθερου υδατικου διαλυματος λυσινικης ιμπουπροφαινης για ενδοκολπικη χρηση
CN108686252B (zh) * 2018-06-11 2021-05-18 深圳英凡妮生物科技有限公司 一种以壳聚糖-泊洛沙姆为基质的纳米银抗菌敷料及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639576A (en) * 1968-06-19 1972-02-01 Barnes Hind Pharm Inc Resterilizing contact lens solution
BE901885A (fr) * 1985-03-06 1985-07-01 Bruschettini Srl Composition pharmaceutique sous forme de lotion ophtalmique et son procede de preparation.
US4931225A (en) * 1987-12-30 1990-06-05 Union Carbide Industrial Gases Technology Corporation Method and apparatus for dispersing a gas into a liquid
US4853088A (en) * 1988-04-12 1989-08-01 Marathon Oil Company Solar enhanced separation of volatile components from a liquid
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them
IT1258781B (it) * 1992-01-16 1996-02-29 Zambon Spa Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
JPH07286027A (ja) * 1994-04-19 1995-10-31 Hoya Corp 眼装着用レンズ材料及びそれを用いた眼装着用レンズ
US5597519A (en) * 1994-06-10 1997-01-28 Johnson & Johnson Vision Products, Inc. Ultraviolet cycling oven for polymerization of contact lenses
US5922249A (en) * 1995-12-08 1999-07-13 Novartis Ag Ophthalmic lens production process
JP3689900B2 (ja) * 1998-08-19 2005-08-31 ニプロ株式会社 医療用成形品
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
US20020037897A1 (en) * 2000-08-07 2002-03-28 3-Dimensional Pharmaceuticals, Inc. Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
AU2002345015A1 (en) * 2001-06-08 2002-12-23 Novartis Pharma Gmbh Ophthalmic once-a-day composition
US20060100408A1 (en) * 2002-03-11 2006-05-11 Powell P M Method for forming contact lenses comprising therapeutic agents
DE20217473U1 (de) * 2002-11-11 2003-03-27 Analysen Service GmbH Umwelt- und Öllabor Leipzig, 04277 Leipzig Entgasungsmodul für Fluidproben
JP2005124809A (ja) * 2003-10-23 2005-05-19 Sanyo Chem Ind Ltd 医療用接着剤
FR2894154B1 (fr) * 2005-12-06 2008-03-14 Pharmatop Scr Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation.

Also Published As

Publication number Publication date
EP1769834A3 (en) 2009-10-07
US20070077303A1 (en) 2007-04-05
KR20070037415A (ko) 2007-04-04
CA2561676A1 (en) 2007-03-30
CN1939278A (zh) 2007-04-04
TW200730468A (en) 2007-08-16
EP1769834A2 (en) 2007-04-04
AR057526A1 (es) 2007-12-05
JP2007099768A (ja) 2007-04-19
SG131101A1 (en) 2007-04-26
AU2006225174B2 (en) 2012-07-05
AU2006225174A1 (en) 2007-04-19
US20110201596A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
UA99624C2 (uk) Сульфонаміди як trpm8-модулятори
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
BR112015024601A2 (pt) mistura de éter amina, processo para fabricação de uma mistura de éter amina, e, uso de uma mistura de éter amina
BRPI0816911A8 (pt) Processo para preparação de 4-aminobut-2-enolidas
ECSP11010812A (es) Complejo de mineral-aminoácido polisacárido
BRPI0509184A (pt) composições farmacêuticas
BRPI0518904A2 (pt) formulaÇÕes de nepafenac tàpicas
AR064327A1 (es) Un metodo para preparar montelukast e intermediarios utilizados en el mismo
EA200900397A1 (ru) Новые соединения диосметина, способ их получения и фармацевтические композиции, которые их содержат
CR10548A (es) 18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen
BRPI0712889A8 (pt) composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica.
BRPI0604723A (pt) método para prover composições oftálmicas oxidativamente estáveis
BR112013005434A2 (pt) novo mono-hidrato de derivados de aza-adamantano
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
HN2009000856A (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
DK1948131T3 (da) Dexpanthenol-, calciumion- og phosphatfri farmaceutisk sammensætning samt anvendelse af calciumchelatdannere og oftalmologisk kompatible viskositetsregulatorer
EA200800810A1 (ru) Соль глюкуроновой кислоты и соединения пиперазина
BRPI0517390B8 (pt) processo para a preparação de derivados de [1,4,5]-oxadiazepam
BRPI0909695B8 (pt) processo de redução, processo de preparação de compostos e processo de preparação de nebivolol
BRPI0513712A (pt) método para a preparação de derivado de d-eritro-2,2-difluoro-2-desóxi-1-oxorribose
EA200800393A1 (ru) Новые соединения-аналоги камптотецина, способ их получения и фармацевтические композиции, которые их содержат
TW200728247A (en) Methods for stabilizing ophthalmic compositions
BRPI0922787A2 (pt) Formas polimórficas de um derivado da azabiciclo-trifluorometil benzamida
CR10764A (es) Cristal novedoso de (s)-(+)-2-(2-clorofenil)-2-hidroxietil carbamato

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2325 DE 28-07-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.